Catalent
CTLT
#1792
Rank
NZ$19.52 B
Marketcap
NZ$107.55
Share price
0.00%
Change (1 day)
10.46%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): NZ-$10.40

According to Catalent's latest financial reports the company's current EPS (TTM) is NZ-$10.72. In 2023 the company made an earnings per share (EPS) of NZ-$11.52 a decrease over its 2022 EPS that were of NZ$3.85.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$10.40-9.75%
2023NZ-$11.52-399.56%
2022NZ$3.85-30.58%
2021NZ$5.5479.67%
2020NZ$3.08114.12%
2019NZ$1.44-15%
2018NZ$1.6975.44%
2017NZ$0.97-22.97%
2016NZ$1.25-59.56%
2015NZ$3.10282.05%
2014NZ$0.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ-$0.56-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ-$10.10-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
NZ-$1.27-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
NZ-$2.51-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA